Telix Pharmaceuticals Limited Stock: price and insider trades · Australia

This page follows insider dealings at Telix Pharmaceuticals Limited as filed with ASX, a company from the Health Care sector. Between 18 October 2025 and 18 October 2026, 7 insiders published 25 filings.

On the market, 2 insiders bought (4 purchases totalling €608k) while 1 insider sold (4 sales totalling €26). The totals exclude 3 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. At €608k, the purchase published on 29 April 2026 by Dr Christian Behrenbruch is the largest of the period (0.016% of market cap). On the buying side, the filings list 2 senior executives among the declarants.

Compared with its exchange (2,222 companies, median 3 filings), a count of 25 filings is above the norm. Since 2026, the database holds 4 purchases and 4 sales by insiders of the company.

The last purchase on record was published on 25 September 2026, which is 22 days ago. Filings reach the ASX feed a median of 5 days after the trade. This delay matters because a trade only becomes useful information once it is public.

Elsewhere in the same sector, our signals recently picked up insider purchases at Anixa Biosciences Inc and Vivos Inc. Source: insider filings from ASX. Past trades are no guide to future returns.